Hantavirus-induced disruption of the endothelial barrier: Neutrophils are on the payroll

Frontiers in Microbiology

Volumn 6, Issue MAR, 2015, Pages

  Schönrich, Günther ^a   Krüger, Detlev H ^a   Raftery, Martin J ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Hantaviruses; Immunopathogenesis; Neutrophil extracellular traps; Neutrophils; Vascular hyperpermeability; Viral hemorrhagic fever

Indexed keywords

CD18 ANTIGEN; CHEMOKINE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; VASCULOTROPIN;

ARTICLE; BLOOD VESSEL PERMEABILITY; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL DISRUPTION; CYTOTOXICITY; EXTRACELLULAR TRAP; HANTAVIRUS INFECTION; HEMORRHAGIC FEVER; HUMAN; IMMUNOPATHOGENESIS; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; RESPIRATORY DISTRESS; THROMBOCYTE ACTIVATION; UPREGULATION; VIRUS PATHOGENESIS;

HANTAVIRUS;

EID: 84927564661     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2015.00222     Document Type: Article

References (116)

1. Amulic, B., Cazalet, C., Hayes, G. L., Metzler, K. D., and Zychlinsky, A. (2012). Neutrophil function: from mechanisms to disease. Annu. Rev. Immunol. 30, 459-489. doi: 10.1146/annurev-immunol-020711-074942.
2. Antonen, J., Leppanen, I., Tenhunen, J., Arvola, P., Makela, S., Vaheri, A., et al. (2013). A severe case of Puumala hantavirus infection successfully treated with bradykinin receptor antagonist icatibant. Scand. J. Infect. Dis. 45, 494-496. doi: 10.3109/00365548.2012.755268.
3. Bjorkstrom, N. K., Lindgren, T., Stoltz, M., Fauriat, C., Braun, M., Evander, M., et al. (2011). Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus. J. Exp. Med. 208, 13-21. doi: 10.1084/jem.20100762.
4. Blum, M. S., Toninelli, E., Anderson, J. M., Balda, M. S., Zhou, J., O'Donnell, L., et al. (1997). Cytoskeletal rearrangement mediates human microvascular endothelial tight junction modulation by cytokines. Am. J. Physiol. 273, H286-H294.
5. Borges, A. A., Campos, G. M., Moreli, M. L., Moro Souza, R. L., Saggioro, F. P., Figueiredo, G. G., et al. (2008). Role of mixed Th1 and Th2 serum cytokines on pathogenesis and prognosis of hantavirus pulmonary syndrome. Microbes Infect. 10, 1150-1157. doi: 10.1016/j.micinf.2008.06.006.
6. Borges, A. A., Donadi, E. A., Campos, G. M., Moreli, M. L., de Sousa, R. L., Saggioro, F. P., et al. (2010). Association of-308G/A polymorphism in the tumor necrosis factor-α gene promoter with susceptibility to development of hantavirus cardiopulmonary syndrome in the Ribeirao Preto region, Brazil. Arch. Virol. 155, 971-975. doi: 10.1007/s00705-010-0655-7.
7. Bossi, F., Peerschke, E. I., Ghebrehiwet, B., and Tedesco, F. (2011). Cross-talk between the complement and the kinin system in vascular permeability. Immunol. Lett. 140, 7-13. doi: 10.1016/j.imlet.2011.06.006.
8. Braun, M., Bjorkstrom, N. K., Gupta, S., Sundstrom, K., Ahlm, C., Klingstrom, J., et al. (2014). NK cell activation in human hantavirus infection explained by virus-induced IL-15/IL15Ra expression. PLoS Pathog. 10:e1004521. doi: 10.1371/journal.ppat.1004521.
9. Brinkmann, V., Reichard, U., Goosmann, C., Fauler, B., Uhlemann, Y., Weiss, D. S., et al. (2004). Neutrophil extracellular traps kill bacteria. Science 303, 1532-1535. doi: 10.1126/science.1092385.
10. Caudrillier, A., Kessenbrock, K., Gilliss, B. M., Nguyen, J. X., Marques, M. B., Monestier, M., et al. (2012). Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury. J. Clin. Invest. 122, 2661-2671. doi: 10.1172/JCI61303.
11. Charbonnel, N., Pages, M., Sironen, T., Henttonen, H., Vapalahti, O., Mustonen, J., et al. (2014). Immunogenetic factors affecting susceptibility of humans and rodents to hantaviruses and the clinical course of hantaviral disease in humans. Viruses 6, 2214-2241. doi: 10.3390/v6052214.
12. Clark, S. R., Ma, A. C., Tavener, S. A., McDonald, B., Goodarzi, Z., Kelly, M. M., et al. (2007). Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat. Med. 13, 463-469. doi: 10.1038/nm1565.
13. Clement, J., Colson, P., and McKenna, P. (1994). Hantavirus pulmonary syndrome in New England and Europe. N. Engl. J. Med. 331, 545-546. doi: 10.1056/NEJM199408253310813.
14. Clement, J., Maes, P., and Van, R. M. (2014). Hemorrhagic fever with renal syndrome in the new, and Hantavirus Pulmonary Syndrome in the old world: paradi(se)gm lost or regained? Virus Res. 187, 55-58. doi: 10.1016/j.virusres.2013.12.036.
15. Duchin, J. S., Koster, F. T., Peters, C. J., Simpson, G. L., Tempest, B., Zaki, S. R., et al. (1994). Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. The Hantavirus Study Group. N. Engl. J. Med. 330, 949-955. doi: 10.1056/NEJM199404073301401.
16. Fang, L. Z., Zhao, L., Wen, H. L., Zhang, Z. T., Liu, J. W., He, S. T., et al. (2015). Reservoir host expansion of hantavirus, china. Emerg. Infect. Dis. 21, 170-171. doi: 10.3201/eid2101.140960.
17. Finsterbusch, M., Voisin, M. B., Beyrau, M., Williams, T. J., and Nourshargh, S. (2014). Neutrophils recruited by chemoattractants in vivo induce microvascular plasma protein leakage through secretion of TNF. J. Exp. Med. 211, 1307-1314. doi: 10.1084/jem.20132413.
18. Fuchs, T. A., Bhandari, A. A., and Wagner, D. D. (2011). Histones induce rapid and profound thrombocytopenia in mice. Blood 118, 3708-3714. doi: 10.1182/blood-2011-01-332676.
19. Gavrilovskaya, I., Gorbunova, E., Koster, F., and Mackow, E. (2012). Elevated VEGF levels in pulmonary edema fluid and PBMCs from patients with acute Hantavirus Pulmonary Syndrome. Adv. Virol. 2012, 674360. doi: 10.1155/2012/674360.
20. Gavrilovskaya, I. N., Gorbunova, E. E., Mackow, N. A., and Mackow, E. R. (2008). Hantaviruses direct endothelial cell permeability by sensitizing cells to the vascular permeability factor, VEGF, while angiopoietin-1 and sphingosine 1-phosphate inhibit hantavirus-directed permeability. J. Virol. 82, 5797-5806. doi: 10.1128/JVI.02397-07.
21. Geimonen, E., Neff, S., Raymond, T., Kocer, S. S., Gavrilovskaya, I. N., and Mackow, E. R. (2002). Pathogenic and nonpathogenic hantaviruses differentially regulate endothelial cell responses. Proc. Natl. Acad. Sci. U.S.A. 99, 13837-13842. doi: 10.1073/pnas.192298899.
22. Gizzi, M., Delaere, B., Weynand, B., Clement, J., Maes, P., Vergote, V., et al. (2013). Another case of "European hantavirus pulmonary syndrome" with severe lung, prior to kidney, involvement, and diagnosed by viral inclusions in lung macrophages. Eur. J. Clin. Microbiol. Infect. Dis. 32, 1341-1345. doi: 10.1007/s10096-013-1885-x.
23. Gorbunova, E., Gavrilovskaya, I. N., and Mackow, E. R. (2010). Pathogenic hantaviruses Andes virus and Hantaan virus induce adherens junction disassembly by directing vascular endothelial cadherin internalization in human endothelial cells. J. Virol. 84, 7405-7411. doi: 10.1128/JVI.00576-10.
24. Guidotti, L. G., and Chisari, F. V. (2001). Noncytolytic control of viral infections by the innate and adaptive immune response. Annu. Rev. Immunol. 19, 65-91. doi: 10.1146/annurev.immunol.19.1.65.
25. Gupta, A. K., Joshi, M. B., Philippova, M., Erne, P., Hasler, P., Hahn, S., et al. (2010). Activated endothelial cells induce neutrophil extracellular traps and are susceptible to NETosis-mediated cell death. FEBS Lett. 584, 3193-3197. doi: 10.1016/j.febslet.2010.06.006.
26. Gupta, S., Braun, M., Tischler, N. D., Stoltz, M., Sundstrom, K. B., Bjorkstrom, N. K., et al. (2013). Hantavirus-infection confers resistance to cytotoxic lymphocyte-mediated apoptosis. PLoS. Pathog. 9:e1003272. doi: 10.1371/journal.ppat.1003272.
27. Hayasaka, D., Maeda, K., Ennis, F. A., and Terajima, M. (2007). Increased permeability of human endothelial cell line EA.hy926 induced by hantavirus-specific cytotoxic T lymphocytes. Virus Res. 123, 120-127. doi: 10.1016/j.virusres.2006.08.006.
28. Hjelle, B., Jenison, S. A., Goade, D. E., Green, W. B., Feddersen, R. M., and Scott, A. A. (1995). Hantaviruses: clinical, microbiologic, and epidemiologic aspects. Crit. Rev. Clin. Lab. Sci. 32, 469-508. doi: 10.3109/10408369509082592.
29. Hooper, J. W., Brocato, R. L., Kwilas, S. A., Hammerbeck, C. D., Josleyn, M. D., Royals, M., et al. (2014). DNA vaccine-derived human IgG produced in transchromosomal bovines protect in lethal models of hantavirus pulmonary syndrome. Sci. Transl. Med. 6, 264ra162. doi: 10.1126/scitranslmed.3010082.
30. Jahnsen, F. L., Strickland, D. H., Thomas, J. A., Tobagus, I. T., Napoli, S., Zosky, G. R., et al. (2006). Accelerated antigen sampling and transport by airway mucosal dendritic cells following inhalation of a bacterial stimulus. J. Immunol. 177, 5861-5867. doi: 10.4049/jimmunol.177.9.5861.
31. Jaillon, S., Peri, G., Delneste, Y., Fremaux, I., Doni, A., Moalli, F., et al. (2007). The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular traps. J. Exp. Med. 204, 793-804. doi: 10.1084/jem.20061301.
32. Jenne, C. N., Wong, C. H., Zemp, F. J., McDonald, B., Rahman, M. M., Forsyth, P. A., et al. (2013). Neutrophils recruited to sites of infection protect from virus challenge by releasing neutrophil extracellular traps. Cell Host Microbe 13, 169-180. doi: 10.1016/j.chom.2013.01.005.
33. Jonsson, C. B., Figueiredo, L. T., and Vapalahti, O. (2010). A global perspective on hantavirus ecology, epidemiology, and disease. Clin. Microbiol. Rev. 23, 412-441. doi: 10.1128/CMR.00062-09.
34. Kanerva, M., Vaheri, A., Mustonen, J., and Partanen, J. (1998). High-producer allele of tumour necrosis factor-alpha is part of the susceptibility MHC haplotype in severe Puumala virus-induced nephropathia epidemica. Scand. J. Infect. Dis. 30, 532-534. doi: 10.1080/00365549850161629.
35. Khaiboullina, S. F., Netski, D. M., Krumpe, P., and St Jeor, S. C. (2000). Effects of tumor necrosis factor alpha on sin nombre virus infection in vitro. J. Virol. 74, 11966-11971. doi: 10.1128/JVI.74.24.11966-11971.2000.
36. Khaiboullina, S. F., Rizvanov, A. A., Lombardi, V. C., Morzunov, S. P., Reis, H. J., Palotas, A., et al. (2013). Andes-virus-induced cytokine storm is partially suppressed by ribavirin. Antivir. Ther. 18, 575-584. doi: 10.3851/IMP2524.
37. Klempa, B., Meisel, H., Rath, S., Bartel, J., Ulrich, R., and Kruger, D. H. (2003). Occurrence of renal and pulmonary syndrome in a region of northeast Germany where Tula hantavirus circulates. J. Clin. Microbiol. 41, 4894-4897. doi: 10.1128/JCM.41.10.4894-4897.2003.
38. Klingstrom, J., Hardestam, J., Stoltz, M., Zuber, B., Lundkvist, A., Linder, S., et al. (2006). Loss of cell membrane integrity in Puumala hantavirus-infected patients correlates with levels of epithelial cell apoptosis and perforin. J. Virol. 80, 8279-8282. doi: 10.1128/JVI.00742-06.
39. Klingstrom, J., Lindgren, T., and Ahlm, C. (2008). Sex-dependent differences in plasma cytokine responses to hantavirus infection. Clin. Vaccine Immunol. 15, 885-887. doi: 10.1128/CVI.00035-08.
40. Koma, T., Yoshimatsu, K., Nagata, N., Sato, Y., Shimizu, K., Yasuda, S. P., et al. (2014). Neutrophil depletion suppresses pulmonary vascular hyperpermeability and occurrence of pulmonary edema caused by hantavirus infection in C.B-17 SCID mice. J. Virol. 88, 7178-7188. doi: 10.1128/JVI.00254-14.
41. Kraus, A. A., Raftery, M. J., Giese, T., Ulrich, R., Zawatzky, R., Hippenstiel, S., et al. (2004). Differential antiviral response of endothelial cells after infection with pathogenic and nonpathogenic hantaviruses. J. Virol. 78, 6143-6150. doi: 10.1128/JVI.78.12.6143-6150.2004.
42. Krautkrämer, E., Grouls, S., Hettwer, D., Rafat, N., Tonshoff, B., and Zeier, M. (2014). Mobilization of circulating endothelial progenitor cells correlates with the clinical course of hantavirus disease. J. Virol. 88, 483-489. doi: 10.1128/JVI.02063-13.
43. Krautkrämer, E., Grouls, S., Stein, N., Reiser, J., and Zeier, M. (2011). Pathogenic old world hantaviruses infect renal glomerular and tubular cells and induce disassembling of cell-to-cell contacts. J. Virol. 85, 9811-9823. doi: 10.1128/JVI.00568-11.
44. Krautkrämer, E., Zeier, M., and Plyusnin, A. (2013). Hantavirus infection: an emerging infectious disease causing acute renal failure. Kidney Int. 83, 23-27. doi: 10.1038/ki.2012.360.
45. Krüger, D. H., Figueiredo, L. T., Song, J. W., and Klempa, B. (2015). Hantaviruses-Globally emerging pathogens. J. Clin. Virol. 64, 128-136. doi: 10.1016/j.jcv.2014.08.033.
46. Krüger, D. H., Schönrich, G., and Klempa, B. (2011). Human pathogenic hantaviruses and prevention of infection. Hum. Vaccin. 7, 685-693. doi: 10.4161/hv.7.6.15197.
47. Kwilas, S., Kishimori, J. M., Josleyn, M., Jerke, K., Ballantyne, J., Royals, M., et al. (2014). A hantavirus pulmonary syndrome (HPS) DNA vaccine delivered using a spring-powered jet injector elicits a potent neutralizing antibody response in rabbits and nonhuman primates. Curr. Gene Ther. 14, 200-210. doi: 10.2174/1566523214666140522122633.
48. Kyriakidis, I., and Papa, A. (2013). Serum TNF-a, sTNFR1, IL-6, IL-8 and IL-10 levels in hemorrhagic fever with renal syndrome. Virus Res. 175, 91-94. doi: 10.1016/j.virusres.2013.03.020.
49. Laine, O., Makela, S., Mustonen, J., Huhtala, H., Szanto, T., Vaheri, A., et al. (2010). Enhanced thrombin formation and fibrinolysis during acute Puumala hantavirus infection. Thromb. Res. 126, 154-158. doi: 10.1016/j.thromres.2010.05.025.
50. Lalwani, P., Raftery, M. J., Kobak, L., Rang, A., Giese, T., Matthaei, M., et al. (2013). Hantaviral mechanisms driving HLA class I antigen presentation require both RIG-I and TRIF. Eur. J. Immunol. 43, 2566-2576. doi: 10.1002/eji.201243066.
51. Langereis, J. D. (2013). Neutrophil integrin affinity regulation in adhesion, migration, and bacterial clearance. Cell Adh. Migr. 7, 476-481. doi: 10.4161/cam.27293.
52. Lapponi, M. J., Carestia, A., Landoni, V. I., Rivadeneyra, L., Etulain, J., Negrotto, S., et al. (2013). Regulation of neutrophil extracellular trap formation by anti-inflammatory drugs. J. Pharmacol. Exp. Ther. 345, 430-437. doi: 10.1124/jpet.112.202879.
53. Li, Y., Wang, W., Wang, J. P., Pan, L., Zhang, Y., Yu, H. T., et al. (2012). Elevated vascular endothelial growth factor levels induce hyperpermeability of endothelial cells in hantavirus infection. J. Int. Med. Res. 40, 1812-1821. doi: 10.1177/030006051204000519.
54. Libraty, D. H., Makela, S., Vlk, J., Hurme, M., Vaheri, A., Ennis, F. A., et al. (2012). The degree of leukocytosis and urine GATA-3 mRNA levels are risk factors for severe acute kidney injury in Puumala virus nephropathia epidemica. PLoS ONE 7:e35402. doi: 10.1371/journal.pone.0035402.
55. Linderholm, M., Ahlm, C., Settergren, B., Waage, A., and Tarnvik, A. (1996). Elevated plasma levels of tumor necrosis factor (TNF)-a, soluble TNF receptors, interleukin (IL)-6, and IL-10 in patients with hemorrhagic fever with renal syndrome. J. Infect. Dis. 173, 38-43. doi: 10.1093/infdis/173.1.38.
56. Lukes, R. J. (1954). The pathology of thirty-nine fatal cases of epidemic hemorrhagic fever. Am. J. Med. 16, 639-650. doi: 10.1016/0002-9343(54)90270-3.
57. Ma, Y., Liu, B., Yuan, B., Wang, J., Yu, H., Zhang, Y., et al. (2012). Sustained high level of serum VEGF at convalescent stage contributes to the renal recovery after HTNV infection in patients with hemorrhagic fever with renal syndrome. Clin. Dev. Immunol. 2012, 812386. doi: 10.1155/2012/812386.
58. MacNeil, A., Ksiazek, T. G., and Rollin, P. E. (2011). Hantavirus pulmonary syndrome, United States, 1993-2009. Emerg. Infect. Dis. 17, 1195-1201. doi: 10.3201/eid1707.101306.
59. Maes, P., Clement, J., Groeneveld, P. H., Colson, P., Huizinga, T. W., and Van Ranst, M. (2006). Tumor necrosis factor-α genetic predisposing factors can influence clinical severity in nephropathia epidemica. Viral Immunol. 19, 558-564. doi: 10.1089/vim.2006.19.558.
60. Makela, S., Mustonen, J., Ala-Houhala, I., Hurme, M., Partanen, J., Vapalahti, O., et al. (2002). Human leukocyte antigen-B8-DR3 is a more important risk factor for severe Puumala hantavirus infection than the tumor necrosis factor-a(-308) G/A polymorphism. J. Infect. Dis. 186, 843-846. doi: 10.1086/342413.
61. Markotic, A., Hensley, L., Daddario, K., Spik, K., Anderson, K., and Schmaljohn, C. (2007). Pathogenic hantaviruses elicit different immunoreactions in THP-1 cells and primary monocytes and induce differentiation of human monocytes to dendritic-like cells. Coll. Antropol. 31, 1159-1167.
62. Marsac, D., Garcia, S., Fournet, A., Aguirre, A., Pino, K., Ferres, M., et al. (2011). Infection of human monocyte-derived dendritic cells by ANDES Hantavirus enhances pro-inflammatory state, the secretion of active MMP-9 and indirectly enhances endothelial permeability. Virol. J. 8, 223. doi: 10.1186/1743-422X-8-223.
63. Martinez-Valdebenito, C., Calvo, M., Vial, C., Mansilla, R., Marco, C., Palma, R. E., et al. (2014). Person-to-person household and nosocomial transmission of andes hantavirus, Southern Chile, 2011. Emerg. Infect. Dis. 20, 1629-1636. doi: 10.3201/eid2010.140353.
64. Massberg, S., Grahl, L., von Bruehl, M. L., Manukyan, D., Pfeiler, S., Goosmann, C., et al. (2010). Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases. Nat. Med. 16, 887-896. doi: 10.1038/nm.2184.
65. McDonald, B., Urrutia, R., Yipp, B. G., Jenne, C. N., and Kubes, P. (2012). Intravascular neutrophil extracellular traps capture bacteria from the bloodstream during sepsis. Cell Host Microbe 12, 324-333. doi: 10.1016/j.chom.2012.06.011.
66. Metchnikoff, E. (1887). Sur la lutte des cellules de l'organisme contre l'invasion de microbes. Ann. Inst. Pasteur. 1, 321-326.
67. Monsinjon, T., Gasque, P., Chan, P., Ischenko, A., Brady, J. J., and Fontaine, M. C. (2003). Regulation by complement C3a and C5a anaphylatoxins of cytokine production in human umbilical vein endothelial cells. FASEB J. 17, 1003-1014. doi: 10.1096/fj.02-0737com.
68. Mori, M., Rothman, A. L., Kurane, I., Montoya, J. M., Nolte, K. B., Norman, J. E., et al. (1999). High levels of cytokine-producing cells in the lung tissues of patients with fatal hantavirus pulmonary syndrome. J. Infect. Dis. 179, 295-302. doi: 10.1086/314597.
69. Mustonen, J., Makela, S., Outinen, T., Laine, O., Jylhava, J., Arstila, P. T., et al. (2013). The pathogenesis of nephropathia epidemica: new knowledge and unanswered questions. Antiviral Res. 100, 589-604. doi: 10.1016/j.antiviral.2013.10.001.
70. Nauseef, W. M., and Borregaard, N. (2014). Neutrophils at work. Nat. Immunol. 15, 602-611. doi: 10.1038/ni.2921.
71. Nichol, S. T., Spiropoulou, C. F., Morzunov, S., Rollin, P. E., Ksiazek, T. G., Feldmann, H., et al. (1993). Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. Science 262, 914-917. doi: 10.1126/science.8235615.
72. Niikura, M., Maeda, A., Ikegami, T., Saijo, M., Kurane, I., and Morikawa, S. (2004). Modification of endothelial cell functions by Hantaan virus infection: prolonged hyper-permeability induced by TNF-α of hantaan virus-infected endothelial cell monolayers. Arch. Virol. 149, 1279-1292. doi: 10.1007/s00705-004-0306-y.
73. Nolte, K. B., Feddersen, R. M., Foucar, K., Zaki, S. R., Koster, F. T., Madar, D., et al. (1995). Hantavirus pulmonary syndrome in the United States: a pathological description of a disease caused by a new agent. Hum. Pathol. 26, 110-120. doi: 10.1016/0046-8177(95)90123-X.
74. Ontiveros, S. J., Li, Q., and Jonsson, C. B. (2010). Modulation of apoptosis and immune signaling pathways by the Hantaan virus nucleocapsid protein. Virology 401, 165-178. doi: 10.1016/j.virol.2010.02.018.
75. Outinen, T. K., Kuparinen, T., Jylhava, J., Leppanen, S., Mustonen, J., Makela, S., et al. (2012a). Plasma cell-free DNA levels are elevated in acute Puumala hantavirus infection. PLoS ONE 7:e31455. doi: 10.1371/journal.pone.0031455.
76. Outinen, T. K., Makela, S., Huhtala, H., Hurme, M., Meri, S., Porsti, I., et al. (2012b). High pentraxin-3 plasma levels associate with thrombocytopenia in acute Puumala hantavirus-induced nephropathia epidemica. Eur. J. Clin. Microbiol. Infect. Dis. 31, 957-963. doi: 10.1007/s10096-011-1392-x.
77. Ozaki, H., Ishii, K., Horiuchi, H., Arai, H., Kawamoto, T., Okawa, K., et al. (1999). Cutting edge: combined treatment of TNF-α and IFN-γ causes redistribution of junctional adhesion molecule in human endothelial cells. J. Immunol. 163, 553-557.
78. Paakkala, A., Mustonen, J., Viander, M., Huhtala, H., and Pasternack, A. (2000). Complement activation in nephropathia epidemica caused by Puumala hantavirus. Clin. Nephrol. 53, 424-431.
79. Pensiero, M. N., Sharefkin, J. B., Dieffenbach, C. W., and Hay, J. (1992). Hantaan virus infection of human endothelial cells. J. Virol. 66, 5929-5936.
80. Pergam, S. A., Schmidt, D. W., Nofchissey, R. A., Hunt, W. C., Harford, A. H., and Goade, D. E. (2009). Potential renal sequelae in survivors of hantavirus cardiopulmonary syndrome. Am. J. Trop. Med. Hyg. 80, 279-285.
81. Pillay, J., Kamp, V. M., van, H. E., Visser, T., Tak, T., Lammers, J. W., et al. (2012). A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1. J. Clin. Invest. 122, 327-336. doi: 10.1172/JCI57990.
82. Pober, J. S. (2002). Endothelial activation: intracellular signaling pathways. Arthritis Res. 4(Suppl. 3), S109-S116. doi: 10.1186/ar576.
83. Raftery, M. J., Kraus, A. A., Ulrich, R., Krüger, D. H., and Schönrich, G. (2002). Hantavirus infection of dendritic cells. J. Virol. 76, 10724-10733. doi: 10.1128/JVI.76.21.10724-10733.2002.
84. Raftery, M. J., Lalwani, P., Krautkrämer, E., Peters, T., Scharffetter-Kochanek, K., Krüger, R., et al. (2014). β2 integrin mediates hantavirus-induced release of neutrophil extracellular traps. J. Exp. Med. 211, 1485-1497. doi: 10.1084/jem.20131092.
85. Rasmuson, J., Andersson, C., Norrman, E., Haney, M., Evander, M., and Ahlm, C. (2011a). Time to revise the paradigm of hantavirus syndromes? Hantavirus pulmonary syndrome caused by European hantavirus. Eur. J. Clin. Microbiol. Infect. Dis. 30, 685-690. doi: 10.1007/s10096-010-1141-6.
86. Rasmuson, J., Pourazar, J., Linderholm, M., Sandstrom, T., Blomberg, A., and Ahlm, C. (2011b). Presence of activated airway T lymphocytes in human puumala hantavirus disease. Chest 140, 715-722. doi: 10.1378/chest.10-2791.
87. Razakandrainibe, R., Combes, V., Grau, G. E., and Jambou, R. (2013). Crossing the wall: the opening of endothelial cell junctions during infectious diseases. Int. J. Biochem. Cell Biol. 45, 1165-1173. doi: 10.1016/j.biocel.2013.03.010.
88. Razvina, O., Jiang, S., Matsubara, K., Ohashi, R., Hasegawa, G., Aoyama, T., et al. (2014). Differential expression of pentraxin 3 in neutrophils. Exp. Mol. Pathol. 98, 33-40. doi: 10.1016/j.yexmp.2014.11.009.
89. Sadeghi, M., Eckerle, I., Daniel, V., Burkhardt, U., Opelz, G., and Schnitzler, P. (2011). Cytokine expression during early and late phase of acute Puumala hantavirus infection. BMC Immunol. 12:65. doi: 10.1186/1471-2172-12-65.
90. Saffarzadeh, M., Juenemann, C., Queisser, M. A., Lochnit, G., Barreto, G., Galuska, S. P., et al. (2012). Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of histones. PLoS ONE 7:e32366. doi: 10.1371/journal.pone.0032366.
91. Safronetz, D., Feldmann, H., and de, W. E. (2015). Birth and pathogenesis of rogue respiratory viruses. Annu. Rev. Pathol. 10, 449-471. doi: 10.1146/annurev-pathol-012414-040501.
92. Saksida, A., Wraber, B., and Avsic-Zupanc, T. (2011). Serum levels of inflammatory and regulatory cytokines in patients with hemorrhagic fever with renal syndrome. BMC Infect. Dis. 11:142. doi: 10.1186/1471-2334-11-142.
93. Sane, J., Laine, O., Makela, S., Paakkala, A., Jarva, H., Mustonen, J., et al. (2012). Complement activation in Puumala hantavirus infection correlates with disease severity. Ann. Med. 44, 468-475. doi: 10.3109/07853890.2011.573500.
94. Schmaljohn, C. (2009). Vaccines for hantaviruses. Vaccine 27(Suppl. 4), D61-D64. doi: 10.1016/j.vaccine.2009.07.096.
95. Schmaljohn, C. S., and Nichol, S. T. (2007). "Bunyaviridae, "in Fields Virology, eds D. M. Knipe and P. M. Howley (Philadelphia, PA: Lippincott Williams & Wilkins), 1741-1789.
96. Schönrich, G., Rang, A., Lutteke, N., Raftery, M. J., Charbonnel, N., and Ulrich, R. G. (2008). Hantavirus-induced immunity in rodent reservoirs and humans. Immunol. Rev. 225, 163-189. doi: 10.1111/j.1600-065X.2008.00694.x.
97. Schulte, D., Kuppers, V., Dartsch, N., Broermann, A., Li, H., Zarbock, A., et al. (2011). Stabilizing the VE-cadherin-catenin complex blocks leukocyte extravasation and vascular permeability. EMBO J. 30, 4157-4170. doi: 10.1038/emboj.2011.304.
98. Shin, O. S., Yanagihara, R., and Song, J. W. (2012). Distinct innate immune responses in human macrophages and endothelial cells infected with shrew-borne hantaviruses. Virology 434, 43-49. doi: 10.1016/j.virol.2012.08.004.
99. Shrivastava-Ranjan, P., Rollin, P. E., and Spiropoulou, C. F. (2010). Andes virus disrupts the endothelial cell barrier by induction of vascular endothelial growth factor and downregulation of VE-cadherin. J. Virol. 84, 11227-11234. doi: 10.1128/JVI.01405-10.
100. Sundstrom, J. B., McMullan, L. K., Spiropoulou, C. F., Hooper, W. C., Ansari, A. A., Peters, C. J., et al. (2001). Hantavirus infection induces the expression of RANTES and IP-10 without causing increased permeability in human lung microvascular endothelial cells. J. Virol. 75, 6070-6085. doi: 10.1128/JVI.75.13.6070-6085.2001.
101. Taichman, N. S., Young, S., Cruchley, A. T., Taylor, P., and Paleolog, E. (1997). Human neutrophils secrete vascular endothelial growth factor. J. Leukoc. Biol. 62, 397-400.
102. Taylor, S. L., Frias-Staheli, N., Garcia-Sastre, A., and Schmaljohn, C. S. (2009). Hantaan virus nucleocapsid protein binds to importin a proteins and inhibits tumor necrosis factor alpha-induced activation of nuclear factor kappa B. J. Virol. 83, 1271-1279. doi: 10.1128/JVI.00986-08.
103. Taylor, S. L., Wahl-Jensen, V., Copeland, A. M., Jahrling, P. B., and Schmaljohn, C. S. (2013). Endothelial cell permeability during hantavirus infection involves factor XII-dependent increased activation of the kallikrein-kinin system. PLoS. Pathog. 9:e1003470. doi: 10.1371/journal.ppat.1003470.
104. Temonen, M., Mustonen, J., Helin, H., Pasternack, A., Vaheri, A., and Holthofer, H. (1996). Cytokines, adhesion molecules, and cellular infiltration in nephropathia epidemica kidneys: an immunohistochemical study. Clin. Immunol. Immunopathol. 78, 47-55. doi: 10.1006/clin.1996.0007.
105. Temonen, M., Vapalahti, O., Holthofer, H., Brummer-Korvenkontio, M., Vaheri, A., and Lankinen, H. (1993). Susceptibility of human cells to Puumala virus infection. J. Gen. Virol. 74(Pt 3), 515-518. doi: 10.1099/0022-1317-74-3-515.
106. Terajima, M., and Ennis, F. A. (2011). T cells and pathogenesis of hantavirus cardiopulmonary syndrome and hemorrhagic fever with renal syndrome. Viruses 3, 1059-1073. doi: 10.3390/v3071059.
107. Tracey, K. J., and Cerami, A. (1994). Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu. Rev. Med. 45, 491-503. doi: 10.1146/annurev.med.45.1.491.
108. Vaheri, A., Strandin, T., Jaaskelainen, A. J., Vapalahti, O., Jarva, H., Lokki, M. L., et al. (2014). Pathophysiology of a severe case of Puumala hantavirus infection successfully treated with bradykinin receptor antagonist icatibant. Antiviral Res. 111C, 23-25. doi: 10.1016/j.antiviral.2014.08.007.
109. Vial, P. A., Valdivieso, F., Ferres, M., Riquelme, R., Rioseco, M. L., Calvo, M., et al. (2013). High-dose intravenous methylprednisolone for hantavirus cardiopulmonary syndrome in Chile: a double-blind, randomized controlled clinical trial. Clin. Infect. Dis. 57, 943-951. doi: 10.1093/cid/cit394.
110. Villanueva, E., Yalavarthi, S., Berthier, C. C., Hodgin, J. B., Khandpur, R., Lin, A. M., et al. (2011). Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus. J. Immunol. 187, 538-552. doi: 10.4049/jimmunol.1100450.
111. Wimer, B. M. (1998). Implications of the analogy between recombinant cytokine toxicities and manifestations of hantavirus infections. Cancer Biother. Radiopharm. 13, 193-207. doi: 10.1089/cbr.1998.13.193.
112. Xu, J., Zhang, X., Pelayo, R., Monestier, M., Ammollo, C. T., Semeraro, F., et al. (2009). Extracellular histones are major mediators of death in sepsis. Nat. Med. 15, 1318-1321. doi: 10.1038/nm.2053.
113. Yu, H., Jiang, W., Du, H., Xing, Y., Bai, G., Zhang, Y., et al. (2014). Involvement of the Akt/NF-κB pathways in the HTNV-mediated increase of IL-6, CCL5, ICAM-1, and VCAM-1 in HUVECs. PLoS ONE 9:e93810. doi: 10.1371/journal.pone.0093810.
114. Zaki, S. R., Greer, P. W., Coffield, L. M., Goldsmith, C. S., Nolte, K. B., Foucar, K., et al. (1995). Hantavirus pulmonary syndrome. Pathogenesis of an emerging infectious disease. Am. J. Pathol. 146, 552-579.
115. Zapata, J. C., Cox, D., and Salvato, M. S. (2014). The role of platelets in the pathogenesis of viral hemorrhagic fevers. PLoS Negl. Trop. Dis. 8:e2858. doi: 10.1371/journal.pntd.0002858.
116. Zelena, H., Mrazek, J., and Kuhn, T. (2013). Tula hantavirus infection in immunocompromised host, Czech Republic. Emerg. Infect. Dis. 19, 1873-1875. doi: 10.3201/eid1911.130421.